Barclays Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $9
TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Scotiabank Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6
A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $6 to $10
Scotiabank Keeps Their Buy Rating on Geron (GERN)
Robust Market Potential and Strategic Positioning Drive Optimistic Buy Rating for Geron
H.C. Wainwright Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $8
Geron Analyst Ratings
H.C. Wainwright Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $8
Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $7
Geron Price Target Announced at $6.00/Share by Scotiabank
Geron Analyst Ratings
Geron Initiated With an Outperform at Scotiabank
Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $7
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Goldman Sachs Maintains Geron(GERN.US) With Buy Rating, Announces Target Price $6
Buy Rating on Geron Corp: Rytelo's Reimbursement and Market Adoption Promise Peak Sales
Goldman Sachs Maintains Geron(GERN.US) With Buy Rating
Goldman Sachs Reaffirms Their Buy Rating on Geron (GERN)